Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts

British Journal of Cancer

Volumn 81, Issue 2, 1999, Pages 194-202

  Matsumoto Taniura, N ^a   Matsumoto, K ^a   Nakamura, T ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

HGF; Mammary tumour; Prostaglandin E2; Tumour invasion; Tumour stromal interaction

Indexed keywords

INDOMETACIN; PLASMINOGEN ACTIVATOR; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; SCATTER FACTOR; UROKINASE;

ANIMAL CELL; ARTICLE; BREAST CELL; BREAST TUMOR; CANCER GROWTH; CANCER INVASION; CELL GROWTH; CELL INTERACTION; CELL MOTILITY; CONTROLLED STUDY; FEMALE; FIBROBLAST; FIBROBLAST CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SKIN FIBROBLAST; TUMOR CELL;

EID: 0032867568     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690677     Document Type: Article

References (64)

1. Bellusci S, Moens G, Gaudino G, Comoglio PM, Nakamura T, Thiery JP and Jouanneau J (1994) Creation of hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9: 1091-1099
2. Bennett A, Stamford IF, Berstock DA, Dische F, Singh L and A'Hern RP (1989) Breast cancer, prostaglandins and patient survival. Br J Cancer 59: 268-275
3. Birchmeier C and Birchmeier W (1993) Molecular aspects of mesenchymal epithelial interactions. Annu Rev Cell Biol 9: 511-540
4. Bladt F, Riethmacher D, Isenmann S, Aguzzi A and Birchmeier C (1995) Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376: 768-771
5. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A and Comoglio PM (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641
6. Byers S, Park M, Sommers C and Seslar S (1994) Breast carcinoma: a collective disorder. Breast Cancer Res Treat 31: 203-215
7. Camps JL, Chang S, Hsu TC, Freeman MR, Hong S, Zhau HE, von Eschenbach AC and Chung LW (1990) Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci USA 87: 75-79
8. Colasante A, Mascetra N, Brunetti M, Lattanzio G, Diodoro M, Callagirone S, Musiani P and Aiello FB (1997) Transforming growth factor β1, interleukin-8 and interleukin-1, in non-small-cell lung tumors. Am J Respir Crit Care Med 156: 968-973
9. Furlong RA, Takehara T, Taylor WG, Nakamura T and Rubin JS (1991) Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable. J Cell Sci 100: 173-177
10. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P and Rosen EM (1993) Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90: 1937-1941
11. Grey AM, Schor AM, Rushton G, Ellis I and Schor SL (1989) Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc Natl Acad Sci USA 86: 2438-2442
12. Grobstein C (1967) Mechanisms of organogenetic tissue interactions. Natl Cancer Inst Monogr 26: 279-299
13. Jeffers M, Rong S and Vande Woude GF (1996) Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 16: 1115-1125
14. Jiang WG, Lloyds D, Puntis MC, Nakamura T and Hallett MB (1993) Regulation of spreading and growth of colon cancer cells by hepatocyte growth factor. Clin Exp Metastasis 11: 235-242
15. Jin L, Fuchs A, Schnitt SJ, Yao Y, Joseph A, Lamszus K, Park M, Goldberg ID and Rosen EM (1997a) Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer 79: 749-760
16. Jin L, Yuan RQ, Fuchs A, Yao Y, Joseph A, Schwall R, Schnitt SJ, Guida A, Hastings HM, Andres J, Turkel G, Polverini PJ, Goldberg D, Rosen EM (1997b) Expression of interleukin-1β in human breast carcinoma. Cancer 80: 421-434
17. Karmali RA, Welt S, Thaler HT and Lefevre F (1983) Prostaglandins in breast cancer: relationship to disease stage and hormone status. Br J Cancer 48: 689-696
18. Konishi T, Takehara T, Tsuji T, Ohsato K, Matsumoto K and Nakamura T (1991) Scatter factor from human embryonic lung fibroblasts is probably identical to hepatocyte growth factor. Biochem Biophys Res Commun 180: 765-773
19. Lamszus K, Jin L, Fuchs A, Shi E, Chowdbury S, Yao Y, Polverni PJ, Laterra J, Goldberg ID and Rosen EM (1997) Scatter factor stimulates tumor growth and angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest 76: 339-353
20. Lippman ME and Dickson RB (1990) Growth control of normal and malignant breast epithelium. Prog Clin Biol Res 354A: 147-178
21. Marnett LJ (1995) Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer. Prevent Med 24: 103-106
22. Matsumoto K, Matsumoto K, Nakamura T and Kramer RH (1994) Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125 FAK) and promotes migration and invasion by oral squarnous cell carcinoma cells. J Biol Chem 269: 31807-31813
23. Matsumoto K, Okazaki H and Nakamura T (1995) Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration. J Biochem (Tokyo) 117: 458-464
24. Matsumoto K, Date K, Shimura H and Nakamura T (1996) Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor. Jpn J Cancer Res 87: 702-710
25. Matsumoto K and Nakamura T (1997) Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 239. 639-644
26. Matsunaga T, Gohda E, Takebe T, Wu YL, Iwao M, Kataoka H and Yamamoto I (1994) Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway. Exp Cell Res 210: 326-335
27. Matsuzaki K, Yoshitake Y, Matuo Y, Sasaki H and Nishikawa K (1989) Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc Natl Acad Sci USA 86: 9911-9915
28. Montesano R, Matsumoto K, Nakamura T and Orci L (1991) Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67: 901-908
29. Nagy J, Curry GW, Hillan KJ, McKay IC, Mallon E, Purushotham AD and George WD (1996) Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer. Surg Oncol 5: 15-21
30. Nakamura T, Nawa K and Ichihara A (1984) Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122: 1450-1459
31. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K and Shimizu S (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443
32. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y and Nakamura T (1997) Induction of hepatocyte growth factor in fibroblasts by tumor - derived factors affects invasive growth of tumour cells: in vitro analysis of tumor-stromal interactions. Cancer Res 57: 3305-3313
33. Narisawa T, Kusaka H, Yamazaki Y, Takahashi M, Koyama H, Koyama K, Fukuda Y and Wakizaka A (1990) Relationship between blood plasma prostaglandin E, and liver and lung metastases in colorectal cancer. Dis Colon Rectum 33: 840-845
34. Niranjan B, Buluwela L, Yant J, Perusinghe N, Atherton-A, Phippard D, Dale T, Gusterson B and Kamalati T (1995) HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development 121: 2897-2908
35. Ohmichi H, Koshimizu U, Matsumoto K and Nakamura T (1998) Hepatocyte growth factor (HGF) acts as a mesenchyme-derived morphogenic factor during fetal lung development. Development 125: 1315-1324
36. Picard O, Rolland Y and Poupon MF (1986) Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases. Cancer Res 46: 3290-3294
37. Rahimi N, Tremblay F., McAdam I., Park M, Schwall R and Elliott B (1996) Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma. Cell Growth Differ 7: 263-270
38. Rolland PH, Martin PM, Jacquemier J, Rolland AM and Toga M (1980) Prostaglandin in human breast cancer: evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst 64: 1061-1070
39. Rosen EM, Joseph A, Jin L, Rockwell S, Elias JA, Knesel J, Wines J, McClellan J, Kluger MJ, Goldberg ID and Zitnik R (1994) Regulation of scatter factor production via a soluble inducing factor. J Cell Biol 127: 225-234
40. Rosenberg L (1995) Nonsteroidal anti-inflammatory drugs and cancer, Prev Med 24: 107-109
41. Sakakura T (1991) New aspects of stroma-parenchyma relations in mammary gland differentiation. Int Rev Cytol 125: 165-202
42. Santos OF, Barros EJ, Yang XM, Matsumoto K, Nakamura T, Park M and Nigam SK (1994) Involvement of hepatocyte growth factor in kidney development. Dev Biol 163: 525-529
43. Sasaki M, Nishio M, Sasaki T and Enami J (1991) Identification of mouse mammary fibroblast-derived mammary growth factor as hepatocyte growth factor. Biochem Biophys Res Commun 199: 772-779
44. Seki T, Ihara I, Sugimura A, Shimonishi M, Nishizawa T, Asami O, Hagiya M, Nakamura T and Shimizu S (1990) Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocyte. Biochem Biophys Res Commun 172: 321-327
45. Seslar S, Nakamura T and Byers S (1993) Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors. Cancer Res 53: 1233-1238
46. Soriano JV, Pepper MS, Nakamura T, Orci L and Montesano R (1995) Hepatocyte growth factor stimulates extensive development of branching duet like structures by cloned mammary gland epithelial cells. J Cell Sci 108: 413-430
47. Stoker M, Gherardi E, Perryman M and Gray J (1987) Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 239-242
48. Sykes JA, Whitesearver J and Briggs L (1968) Observations on a cell line producing mammary tumor virus. J Natl Cancer Inst 41: 1315-1327
49. Tabata MJ, Kim K, Liu J, Yamashita K, Matsumura T, Kato J, Iwamoto M, Wakisaka S, Matsumoto K, Nakamura T, Kumegawu M and Kurisu K (1996) Hepatocyte growth factor is involved in the morphogenesis of tooth germ in murine molars. Development 122: 1243-1251
50. Takahashi M, Ota S, Hata Y, Mikami Y, Azuma N, Nakamura T, Terano A and Omata M (1996) Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach. J Clin Invest 98: 2604-2611
51. Tremblay G (1979) Stromal aspects of breast carcinoma. Exp Mol Pathol 31: 248-260
52. Tuck AB, Park M, Sterns EE, Boag A and Elliott BE (1996) Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol 148: 225-232
53. van den Hooff A (1988) Stromal involvement in malignant growth. Adv Cancer Res 50: 159-196
54. Vassalli JD, Dayer JM, Wohlwend A and Belin D (1984) Concomitant secretion of prourokinase and of a plasminogen activator specific inhibitor by cultured human monocytes-macrophages. J Exp Med 159: 1653-1668
55. Vassalli JD and Pepper MS (1994) Tumour biology. Membrane proteases in focus. Nature 370: 14-15
56. Wang Y, Selden AC, Morgan N, Stamp GWH and Hodgson HJF (1994) Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol 144: 675-682
57. Watson J and Chuah SY (1992) Technique for the primary culture of human breast cancer cells and measurement of their prostaglandin secretion. Clin Sci (Colch) 83: 347-352
58. Weidner KM, Behrens J, Vandekerckhove J and Birchmeier W (1990) Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol III: 2097-2108
59. Weidner KM, Arakaki N, Hartmann G, Vandekerckhove J, Weingart S, Rieder H, Fonatsch C, Tsubouchi H, Hishida T, Daikuhara Y and Birchmeier W (1991) Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88: 7001-7005
60. Wernert N (1997) The multiple roles of tumour stroma. Virchows Arch 430: 433-443
61. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T and Shin S (1994) Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 54: 1630-1633
62. Yang Y, Spitzer E, Meyer D, Sachs M, Niemann C, Hartmann G, Weidner KM Birchmeier C and Birchmeier W (1995) Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol 131: 215-226
63. Yao Y, Jin L, Fuchs A, Joseph A, Hastings HM, Goldberg ID and Rosen EM (1996) Scatter factor protein levels in human breast cancers: clinicopathological and biological correlations. AM J Pathol 149: 1707-1717
64. Zarnegar R and Michalopoulos GK (1995) The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 129: 1177-1180